Cargando…

Encapsulation of Ru(II) Polypyridine Complexes for Tumor-Targeted Anticancer Therapy

Ru(II) polypyridine complexes have attracted much attention as anticancer agents because of their unique photophysical, photochemical, and biological properties. Despite their promising therapeutic profile, the vast majority of compounds are associated with poor water solubility and poor cancer sele...

Descripción completa

Detalles Bibliográficos
Autor principal: Karges, Johannes
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AAAS 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10392611/
https://www.ncbi.nlm.nih.gov/pubmed/37849670
http://dx.doi.org/10.34133/bmef.0024
_version_ 1785083004502147072
author Karges, Johannes
author_facet Karges, Johannes
author_sort Karges, Johannes
collection PubMed
description Ru(II) polypyridine complexes have attracted much attention as anticancer agents because of their unique photophysical, photochemical, and biological properties. Despite their promising therapeutic profile, the vast majority of compounds are associated with poor water solubility and poor cancer selectivity. Among the different strategies employed to overcome these pharmacological limitations, many research efforts have been devoted to the physical or covalent encapsulation of the Ru(II) polypyridine complexes into nanoparticles. This article highlights recent developments in the design, preparation, and physicochemical properties of Ru(II) polypyridine complex-loaded nanoparticles for their potential application in anticancer therapy.
format Online
Article
Text
id pubmed-10392611
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher AAAS
record_format MEDLINE/PubMed
spelling pubmed-103926112023-10-17 Encapsulation of Ru(II) Polypyridine Complexes for Tumor-Targeted Anticancer Therapy Karges, Johannes BME Front Review Article Ru(II) polypyridine complexes have attracted much attention as anticancer agents because of their unique photophysical, photochemical, and biological properties. Despite their promising therapeutic profile, the vast majority of compounds are associated with poor water solubility and poor cancer selectivity. Among the different strategies employed to overcome these pharmacological limitations, many research efforts have been devoted to the physical or covalent encapsulation of the Ru(II) polypyridine complexes into nanoparticles. This article highlights recent developments in the design, preparation, and physicochemical properties of Ru(II) polypyridine complex-loaded nanoparticles for their potential application in anticancer therapy. AAAS 2023-08-01 /pmc/articles/PMC10392611/ /pubmed/37849670 http://dx.doi.org/10.34133/bmef.0024 Text en Copyright © 2023 Johannes Karges https://creativecommons.org/licenses/by/4.0/Exclusive licensee Suzhou Institute of Biomedical Engineering and Technology, CAS. No claim to original U.S. Government Works. Distributed under a Creative Commons Attribution License 4.0 (CC BY 4.0) (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Review Article
Karges, Johannes
Encapsulation of Ru(II) Polypyridine Complexes for Tumor-Targeted Anticancer Therapy
title Encapsulation of Ru(II) Polypyridine Complexes for Tumor-Targeted Anticancer Therapy
title_full Encapsulation of Ru(II) Polypyridine Complexes for Tumor-Targeted Anticancer Therapy
title_fullStr Encapsulation of Ru(II) Polypyridine Complexes for Tumor-Targeted Anticancer Therapy
title_full_unstemmed Encapsulation of Ru(II) Polypyridine Complexes for Tumor-Targeted Anticancer Therapy
title_short Encapsulation of Ru(II) Polypyridine Complexes for Tumor-Targeted Anticancer Therapy
title_sort encapsulation of ru(ii) polypyridine complexes for tumor-targeted anticancer therapy
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10392611/
https://www.ncbi.nlm.nih.gov/pubmed/37849670
http://dx.doi.org/10.34133/bmef.0024
work_keys_str_mv AT kargesjohannes encapsulationofruiipolypyridinecomplexesfortumortargetedanticancertherapy